back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-06-13 Tx date 2017-05-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-332,365.0448
-233,468 vol $1.42 each |
104,176 | |
| Filed 2017-06-13 Tx date 2017-05-19 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-79,557.6067
-51,041 vol $1.56 each |
337,644 | |
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
92,756 | ||
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-13 Tx date 2017-05-23 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-146,877.7424
-104,176 vol $1.41 each |
0 | |
| Filed 2017-05-17 Tx date 2017-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,230
+361 vol $8.95 each |
242,433 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
30,000 | |
| Filed 2017-04-25 Tx date 2016-09-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,732,664
+295,929 vol $5.86 each |
343,216 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-114,400
-80,000 vol $1.43 each |
20,000 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JLV Investments, LP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-25,024 vol |
6,256 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JLD Investments, L.P. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-66,212 vol |
16,553 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-968,291 vol |
242,072 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-509,966 vol |
127,491 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
37 - Stock split or consolidation
|
-369,183 vol |
92,295 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
37 - Stock split or consolidation
|
-369,183 vol |
||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants DOJ/SEC Matter Warrant
37 - Stock split or consolidation
|
-968,291 vol |
242,072 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants DOJ/SEC Matter Warrant
37 - Stock split or consolidation
|
-968,291 vol |
||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
37 - Stock split or consolidation
|
-369,183 vol |
92,295 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
37 - Stock split or consolidation
|
-369,183 vol |
||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants Class Action Lawsuit Warrant
37 - Stock split or consolidation
|
-968,291 vol |
242,072 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants Class Action Lawsuit Warrant
37 - Stock split or consolidation
|
-968,291 vol |
||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Rights Phantom Stock Units
37 - Stock split or consolidation
|
-45,440 vol |
11,360 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,600 vol |
29,600 | |
| Filed 2016-12-09 Tx date 2012-06-04 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2012-06-04 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants Class Action Lawsuit Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-23 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants Class Action Lawsuit Warrant
35 - Stock dividend
|
+74,000 vol |
74,000 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants Class Action Lawsuit Warrant
16 - Acquisition or disposition under a prospectus exemption
|
+1,136,363 vol |
1,210,363 | |
| Filed 2016-12-09 Tx date 2016-11-23 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants Class Action Lawsuit Warrant
35 - Stock dividend
|
+461,478 vol |
461,478 | |
| Filed 2016-12-09 Tx date 2016-11-23 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants DOJ/SEC Matter Warrant
35 - Stock dividend
|
+74,000 vol |
74,000 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants DOJ/SEC Matter Warrant
16 - Acquisition or disposition under a prospectus exemption
|
+1,136,363 vol |
1,210,363 | |
| Filed 2016-12-09 Tx date 2012-06-04 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-23 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants DOJ/SEC Matter Warrant
35 - Stock dividend
|
+461,478 vol |
461,478 | |
| Filed 2016-12-08 Tx date 2012-06-04 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants DOJ/SEC Matter Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-02 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JLV Investments, LP (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+31,280 vol |
31,280 | |
| Filed 2016-12-02 Tx date 2012-06-04 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JLV Investments, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-02 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JLD Investments, L.P. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+82,765 vol |
82,765 | |
| Filed 2016-12-02 Tx date 2012-06-04 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JLD Investments, L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-02 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+175,979 vol |
637,457 | |
| Filed 2016-12-02 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,999,998
+1,136,363 vol $1.76 each |
1,210,363 | |
| Filed 2016-06-22 Tx date 2016-06-17 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Rights Phantom Stock Units
56 - Grant of rights
|
+12,800 vol |
56,800 | |
| Filed 2016-06-22 Tx date 2016-06-17 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
45,468 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Aryeh, Jason
8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,287 | ||
| Filed 2015-12-30 Tx date 2015-12-29 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$996.00
+400 vol $2.49 each |
461,478 | |
| Filed 2015-12-30 Tx date 2015-12-29 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+18,000 vol $2.50 each |
461,078 | |
| Filed 2015-07-02 Tx date 2015-06-30 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$102,000
+25,000 vol $4.08 each |
74,000 | |
| Filed 2015-07-02 Tx date 2015-06-30 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$113,500
+25,000 vol $4.54 each |
49,000 | |
| Filed 2015-07-02 Tx date 2015-06-30 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-25,000 vol |
0 | |
| Filed 2015-07-02 Tx date 2015-06-30 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-25,000 vol |
25,000 | |
| Filed 2015-06-19 Tx date 2015-06-16 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Holder: JALAA Equities, LP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$999,360
+288,000 vol $3.47 each |
443,078 | |
| Filed 2015-06-10 Tx date 2014-12-17 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
50,000 | |
| Filed 2015-06-10 Tx date 2013-07-15 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
25,000 | |
| Filed 2015-06-10 Tx date 2013-07-15 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
||
| Filed 2015-06-10 Tx date 2015-06-07 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-12,000 vol |
0 | |
| Filed 2015-06-10 Tx date 2015-06-07 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+20,000 vol |
24,000 | |
| Filed 2015-06-10 Tx date 2015-06-07 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-8,000 vol |
12,000 | |
| Filed 2015-06-10 Tx date 2014-12-17 |
$QLT
QLT Inc. |
Aryeh, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |